Overview
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 12, 2021 | What minority founders must consider before entering the venture-backed startup ecosystem | Sesie Bonsi Contributor Share on Twitter Sesie Bonsi is the founder and CEO of Bleu, a financial technology platform focused on enabling touchless payment experiences. Funding for Black entrepreneurs in the U.S. hit nearly $1.8 billion in t... |
| Jun 14, 2021 | Temasek, Lake Bleu lead $156m Series C round for Chinese vaccine developer RecBio | Premium Rec-Biotechnology (RecBio), a Chinese developer of genetically engineered vaccines, has secured about 1 billion yuan ($156.3 million) in a Series C round of financing jointly led by Singapore state investor Temasek Holdings and Hong... |
| Jun 14, 2021 | Temasek, Lake Bleu lead $156m Series C round for Chinese vaccine developer RecBio | Rec-Biotechnology (RecBio), a Chinese developer of genetically engineered vaccines, has secured about 1 billion yuan ($156.3 million) in a Series C round of financing jointly led by Singapore state investor Temasek Holdings and Hong Kong-ba... |
| Jan 14, 2021 | NMI’s 2020 marked by innovation and sustained leadership in payments enablement technology | “This year has pushed us hard to deliver on our mission to empower software and fintech companies to accept payments in every way, and with the guidance of our experienced senior leadership team, we’ve been able to do just that," said ... |
Reviews 0
FAQ about Bleu
What has the press written about Bleu?
Parsers VC has collected 5 articles mentioning Bleu, among them “What minority founders must consider before entering the venture-backed startup ecosystem” (Sep 12, 2021) and “Temasek, Lake Bleu lead $156m Series C round for Chinese vaccine developer RecBio” (Jun 14, 2021).
Is Bleu still active?
Yes, Bleu is active; its latest activity on Parsers VC dates from Apr 29, 2022.